用动态浊度法定量测定高聚生注射液中细菌内毒素

目的：探讨采用鲎试剂法对高聚生注射液进行细菌内毒素检查的可行性。方法通过试验确定高聚生注射液细菌内毒素检查的最大有效稀释倍数。结果：经干扰试验表明,内毒素的回收率在50％－200％之间。结论：高聚生注射液经最大有效稀释后进行细菌内毒素检查是可行的。     

刺五加注射液的细菌内毒素检查探讨

细菌内毒素检查法与热原检查法相比 ,成本低、快速简便、灵敏度高。为探讨采用细菌内毒素检查法检测刺五加注射液热原的可行性 ,我们进行了鲎试剂灵敏度复核试验、干扰试验 ,结果表明刺五加注射液稀释 2 .85倍 ,用灵敏度为 0 .2 5 EU·ml-1的鲎试剂作细菌内毒素检查 ,仍有干扰。1　实验材料　　鲎试剂 (批号 0 30 4 1 9,标示灵敏度 0 .5 EU·ml-1;批号 0 30 5 0 3,标示灵敏度 0 .2 5 EU· ml-1,福州新北生化工业有限公司 ) ;细菌内毒素工作标准品 (批号 2 0 0 30 3,规格 1 5 0 EU·支 -1,中国药品生物制品检定所 ) ;鲎试剂溶解水 (批号 …     

艾迪注射液细菌内毒素检查方法探讨

目的:建立艾迪注射液细菌内毒素检查方法。方法:根据《中华人民共和国药典》2005年版Ⅱ部收载的细菌内毒素检查法进行。结果:将艾迪注射液稀释至1/6后可消除干扰因素,用标示灵敏度为0.25 EU/mL的鲎试剂检测细菌内毒素是有效的。结论:细菌内毒素检查法准确、可靠,适用于检测艾迪注射液中的内毒素。     

四种氨基酸原料细菌内毒素检查法的研究

依据中国药典2000年版“细菌内毒素检查法”,通过鲎试剂的干扰试验,研究注射用氨基酸原料中细菌内毒素检查法的可行性。结果在2~16倍稀释级下,L-缬氨酸(c=2.5%)和L-异亮氨酸(c=2.5%)对鲎试剂无干扰,检测细菌内毒素的鲎试剂灵敏度≤5.0×102EU.L-1,而在16倍稀释级范围内,L-脯氨酸(c=4.5%)和L-亮氨酸(c=2.0%)对鲎试剂检查法有抑制作用。结论为注射用L-异亮氨酸和L-缬氨酸用灵敏度为5.0×102EU.L-1的鲎试剂检查其细菌内毒素方法可行,可以代替家兔法检查热原。     

鲎试剂在抗淋巴细胞免疫球蛋白热原检测中的应用

报道了鲎试剂在抗淋巴细胞免疫球蛋白内毒素检查中的应用。在用鲎试剂检测细菌内毒素时 ,按中国药典的要求对鲎试剂灵敏度进行标定 ,并作干扰实验 (增强或抑制实验 ) ,然后用鲎试法与家兔法同时测定 15批抗淋巴细胞免疫球蛋白。结果发现三批鲎试剂的灵敏度标示值均正确 ,五批抗淋巴细胞免疫球蛋白半成品在最大有效稀释度 (MVD)时对试验无干扰 ,这两种方法测定结果的符合率达到 91.7%。从而表明鲎试法很有可能代替家兔法     

动态浊度法鲎试剂在23价肺炎球菌多糖疫苗中间产品内毒素检测中的应用探讨

本文通过使用ATi细菌内毒素动态检测仪进行鲎试剂灵敏度复核试验、干扰试验(回收率试验)和23价肺炎球菌多糖疫苗中间产品内毒素检查,对所得试验结果进行数据分析,找出了影响鲎试剂准确性、灵敏性的干扰因素,从而对鲎试剂的正确使用进行探讨,确保该检测方法的专属性、灵敏度,保证检测结果准确可靠。     

明胶中细菌内毒素的检测

作者通过鲎试验法检测多种来源、多个批号的药用明胶中细菌内毒素含量并进行合格批号的干扰试验,证明明胶对鲎试剂有干扰作用,其作用表现为浓度越高干扰越大。抗增液无助于消除明胶对鲎试剂的干扰,而有效的稀释可克服这种干扰。并对明胶及含明胶成份的生物制品在细菌内毒素检测中的限值确定及其试验影响进行了讨论。     

注射用炎琥宁的细菌内毒素检查

目的:建立注射用炎琥宁细菌内毒素检查方法。方法:按《中国药典》2010年版(二部)附录收载的细菌内毒素检查方法,用不同厂家的鲎试剂对不同批号的样品分别进行干扰试验。结果:注射用炎琥宁稀释至质量浓度为0.17mg.mL-1的供试品溶液时对试验无干扰作用。结论:细菌内毒素检查方法可用于注射用炎琥宁的热原检查。     

蛇伤药酒抗毒抗菌作用的实验研究

目的探讨蛇伤药酒抗眼镜蛇毒、内毒素及细菌的效果。方法抗眼镜蛇毒和内毒素试验采用鲎试剂法．抗菌试验采用纸片法。结果眼镜蛇毒与0．5EU／ml鲎试剂产生凝集反应的浓度在5．0ug／ml以上;蛇伤药酒浓度1ml／ml时有抗5倍量眼镜蛇毒的凝集反应;有抗2．5倍量内毒素的凝集反应;对多种细菌有抑制作用。结论蛇伤药酒有抗眼镜蛇毒、抗内毒素和多种病原菌的作用。     

羟乙基淀粉200／0．5细菌内毒素检查

目的对羟乙基淀粉200／0．5细菌内毒素的含量检查。方法细菌内毒索检查采用鲎试剂检测革兰阴性菌产生的细菌内毒索含量。结果试药内毒素检查呈阴性。结论此方法对细菌内毒索的检查符合规定。     

3种革兰氏阴性细菌及其L型内毒素含量的测定

本文采用鲎试剂对大肠杆菌（ＡＴＣＣ２５９２２）、伤寒杆菌、绿脓杆菌（ＡＴＣＣ７８５３）及它们的Ｌ型内毒素的含量进行测定。结果显示细菌型与细菌Ｌ型均具有内毒素,但细菌Ｌ型内毒素含量较细菌型低（约为１／３￣１／２）。因此,认为细菌Ｌ型仍有一定的致病性。     

细菌内毒素检测法在注射用肝复肽检测中的应用

通过对注射用肝复肽稀释后,采用细菌内毒素试验对其进行检测,并与家兔热原试验相比较。结果表明,细菌内毒素试验可以替代家兔热原试验用于注射用肝复肽的检测。     

Effect of lead acetate on the susceptibility of rats to bacterial endotoxins

Selye, H. (Université de Montréal, Montreal, Canada), B. Tuchweber, and L. Bertók. Effect of lead acetate on susceptibility of rats to bacterial endotoxins. J. Bacteriol. 91:884-890. 1966.-A single, normally well-tolerated, intravenous injection of lead acetate increases the sensitivity of the rat to the endotoxins of various gram-negative bacteria about 100,000 times above normal. Under the conditions of these experiments, the mortality and organ changes normally produced by the intravenous injection of 100 mug of Escherichia coli endotoxin were essentially the same as those obtained by use of 1 nanogram in lead-sensitized rats. The sensitizing effect of lead acetate for E. coli endotoxin is greatest when the two agents are given simultaneously. However, considerable sensitization is still detectable when endotoxin is injected up to 1 hr before or 7 hr after sensitization with lead. No sensitization was noted when the endotoxin was administered 24 hr before or after lead acetate. Under our experimental conditions, the minimal dose of lead acetate which could still induce significant sensitization to E. coli endotoxin was 1 mg per 100 g of body weight. Although lead acetate induces a high degree of susceptibility to various endotoxins, other reticuloendothelial blocking agents did not acquire unusual toxicity after pretreatment with lead. Finally, none of the other metals or reticuloendothelial blocking agents tested could duplicate the pronounced decrease in endotoxin resistance induced by lead acetate.     

Gram-Negative Bacterial Lipopolysaccharide Retention by a Positively Charged New-Generation Filter

Removing endotoxins is an important target in the pharmaceutical industry and in clinical practice. A filter introduced into an intravenous line prevents microbiological contamination, but to date no filters have retained bacterial endotoxins. In our study, we assayed a new-generation filter which is able to capture endotoxins from solutions.     

A comparison of the prophylactic and therapeutic effects of poly I:C and endotoxin in mice infected with Mengo virus.

We have compared the protective effect in AKR mice of poly I:C and bacterial endotoxins against lethal doses of Mengo virus. Administered intravenously or intraperitoneally, both interferon inducers protected mice to about the same extent from virus challenges of 2-3 LD50's. Endotoxin, however, was unable to protect the mice effectively against higher challenge doses of virus. Evidence is presented that the level of protection afforded by both inducers is related to the level of circulating interferon produced. We have also shown that a single intravenous dose of poly I:C results in the appearance of two distinct bursts of interferon activity, with maxima at about 2 h and 9 h post injection. Endotoxin, on the other hand, produced only one peak of activity, at 2 h post injection.     

Preparation of endotoxin-free bacteriophages

Bacteriophages (phages) are bacterial viruses that interact with bacterial walls and invade bacterial cells. Moreover, they disturb bacterial metabolism and lead to bacteria lysis. In the case of Gram-negative bacteria crude phage cultures, apart from the phages themselves, the bacterial debris, bacterial proteins and nucleic acids contain endotoxins. These endotoxins (lipopolysaccharides) posses a high degree of toxicity in vitro and in vivo, and their removal is essential for safety in antibacterial bacteriophage therapy. An effective, scaleable purification of bacteriophages from endotoxins was accomplished by sequential ultrafiltration through polysulfone membrane (30 nm) followed by chromatography on sepharose 4B and Matrex Cellulofine Sulfate. The phage fraction after gel filtration chromatography routinely contained endotoxins in the 150-2500 EU/ml range. The procedure yielded bacteriophages contaminated with as little as 0.4-7 EU/ml (Limulus assay). This value lies within the permitted level for intravenous applications (5 EU/kg/h by European Pharmacopoeia, 1997).     

动态浊度法定量检测静脉注射用人免疫球蛋白中细菌内毒素含量

用鲎试剂动态浊度法定量检测静脉注射用人免疫球蛋白中细菌内毒素含量并与家兔法检测热原的结果进行对比。根据《中华人民共和国》2005年版三部附录中的细菌内毒素动态浊度法制定内毒素限值,用ATi320-06型动态试管仪和该仪器配置的中文软件"生物探针-2002"分析检测结果。静脉注射用人免疫球蛋白经稀释消除了干扰因素,动态浊度法能定量检测出内毒素含量。实验满足2005年版中国药典要求:标准曲线相关系数的绝对值︱r︱≥0.980,回收率:50%≤R≤200%,变异系数符合鲎试剂厂家的建议值CV%10%。检测结果准确、灵敏、稳定、重现性好,与家兔法检测结果相一致。鲎试剂动态浊度法能定量检测静脉注射用人免疫球蛋白中细菌内毒素含量。     

苦碟子注射液辅助治疗对2型糖尿病伴周围神经病变患者微循环的影响

目的:探讨苦碟子注射液辅助治疗对2型糖尿病伴周围神经病变患者微循环影响及安全性。方法:收集我院80例2型糖尿病伴周围神经病变患者,随机分为实验组和对照组,每组40例。对照组患者给予甲钴胺治疗,实验组患者给予苦碟子注射液治疗。观察并比较两组患者治疗前后微循环水平、周围神经评分、不良反应发生率及治疗效果。结果:与治疗前相比,治疗后两组患者管袢形态、管袢流态、袢周状态以及周围神经评分水平较低,差异具有统计学意义(P0.05);与对照组相比,实验组患者治疗管袢形态、管袢流态、袢周状态以及周围神经评分水平较低,差异具有统计学意义(P0.05);实验组并发症的发生率低于对照组,而临床治疗有效率高于对照组,差异均具有统计学意义(P0.05)。结论:苦碟子注射液辅助治疗能够改善患者的微循环以及周围神经情况,临床疗效较好,安全性高。